Jury awards $9 million in damages in hormone replacement drug suit
Tuesday, February 23, 2010
Legal Intelligencer: Amaris Elliott-Engel reports a Philadelphia jury awarded $3.45 million in compensatory damages and $6 million in punitive damages to an Alabama woman who says her breast cancer was caused by Prempro, a hormone replacement therapy drug manufactured by Wyeth, a division of Pfizer. The jury took only four hours to determine the compensatory damages and just seven minutes to settle on the punitive damages. Pfizer’s adjusted income in both 2007 and 2008 was more than $15 billion.